Patacchini R, Cox H M, Ståhl S, Tough I R, Maggi C A
Pharmacology Department, Menarini Ricerche SpA Research Laboratories, Via Rismondo 12/A, 50131, Florence, Italy.
Eur J Pharmacol. 2001 Mar;415(2-3):277-83. doi: 10.1016/s0014-2999(01)00836-6.
We have characterized the tachykinin NK(2) receptor-mediated contraction and vectorial ion transport responses in the muscularis mucosae and mucosa of the rat isolated distal colon, respectively. The tachykinin NK(2) receptor-selective antagonist nepadutant (c([(beta-D-GlcNAc)Asn-Asp-Trp-Phe-Dpr-Leu]c(2beta-5beta))) produced competitive antagonism of [betaAla(8)]neurokinin A-(4-10)-induced contraction (pK(B) = 9.3) in the muscularis mucosae, and insurmountable blockade of increases in short-circuit current (I(sc)) responses (pK(B) = 8.6) in the mucosa. However, this latter effect was completely reversed by washout of the antagonist. [betaAla(8)]Neurokinin A-(4-10)-induced contractions were unaffected by indomethacin (3 microM). In sharp contrast, I(sc) responses induced by [betaAla(8)]neurokinin A-(4-10) (100 nM) were inhibited (>70%) by indomethacin (3 microM), while I(sc) responses to substance P (3 microM) were unchanged. Our study provides the first evidence that in the same organ stimulation of tachykinin NK(2) receptors leads to two independent responses mediated by different effector mechanisms both of which are blocked (albeit with different kinetics) by the potent and selective tachykinin NK(2) receptor antagonist, nepadutant.
我们分别对速激肽NK(2)受体介导的大鼠离体远端结肠肌黏膜收缩反应和黏膜向量离子转运反应进行了表征。速激肽NK(2)受体选择性拮抗剂奈帕肽(c([(β-D-葡糖胺)天冬酰胺-天冬氨酸-色氨酸-苯丙氨酸-D-脯氨酸-亮氨酸]c(2β-5β)))对肌黏膜中[β丙氨酸(8)]神经激肽A-(4-10)诱导的收缩产生竞争性拮抗作用(pK(B)=9.3),并对黏膜中短路电流(I(sc))反应的增加产生不可克服的阻断作用(pK(B)=8.6)。然而,通过洗脱拮抗剂,后一种作用可完全逆转。[β丙氨酸(8)]神经激肽A-(4-10)诱导的收缩不受吲哚美辛(3μM)影响。与之形成鲜明对比的是,吲哚美辛(3μM)可抑制(>70%)[β丙氨酸(8)]神经激肽A-(4-10)(100 nM)诱导的I(sc)反应,而对P物质(3μM)诱导的I(sc)反应无影响。我们的研究首次证明,在同一器官中,速激肽NK(2)受体的刺激会导致由不同效应机制介导的两种独立反应,这两种反应均被强效选择性速激肽NK(2)受体拮抗剂奈帕肽阻断(尽管动力学不同)。